Literature DB >> 34172939

J-shaped curve for the association between serum uric acid levels and the prevalence of blood pressure abnormalities.

Shin Kawasoe1, Takuro Kubozono2, Satoko Ojima1, Takeko Kawabata1, Hironori Miyahara3, Koichi Tokushige3, Mitsuru Ohishi1.   

Abstract

Low and high serum uric acid levels are associated with an increased risk of cardiovascular diseases. However, whether there is a similar association between serum uric acid levels and blood pressure abnormalities has not yet been elucidated. Data from 236,221 individuals (age, 56.0 ± 15.0 years; 107,146 men) who underwent routine health checkups were analyzed. Participants with a serum uric acid level ≤2.0 mg/dL were separated, and the remaining participants were divided into quartiles according to their serum uric acid levels. Among each group, the proportions of participants with high blood pressure (≥130/80 mmHg, and/or medication) and hypertension (≥140/90 mmHg, and/or medication), were calculated. The adjusted odds ratio of each group compared to the group with the lowest proportion of blood pressure abnormalities was calculated. The participants were divided into five groups according to their serum uric acid levels, ≤2.0, 2.1-4.0, 4.1-5.0, 5.1-6.0, and ≥6.1 mg/dL, and the prevalence of high blood pressure was 49.0, 44.6, 52.3, 58.6, and 65.3% and that of hypertension was 31.0, 27.4, 33.5, 38.7, and 43.8%, respectively. Compared to the second-lowest serum uric acid group (2.1-4.0 mg/dL), groups with higher serum uric acid levels (4.1-5.0, 5.1-6.0, and ≥6.1 mg/dL), as well as the group with the lowest serum uric acid level (≤2.0 mg/dL), showed significantly higher odds ratios for high blood pressure and hypertension. High and low serum uric acid levels were significantly associated with an increased prevalence of high blood pressure and followed a J-shaped curve.
© 2021. The Author(s), under exclusive licence to The Japanese Society of Hypertension.

Entities:  

Keywords:  Body mass index; hypertension; renal hypouricemia; sex difference

Mesh:

Substances:

Year:  2021        PMID: 34172939     DOI: 10.1038/s41440-021-00691-5

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  2 in total

Review 1.  Hypouricemia and tubular transport of uric acid.

Authors:  N Esparza Martín; V García Nieto
Journal:  Nefrologia       Date:  2011       Impact factor: 2.033

2.  Patients with renal hypouricemia with exercise-induced acute renal failure and chronic renal dysfunction.

Authors:  Y Kikuchi; H Koga; Y Yasutomo; Y Kawabata; E Shimizu; M Naruse; S Kiyama; H Nonoguchi; K Tomita; Y Sasatomi; S Takebayashi
Journal:  Clin Nephrol       Date:  2000-06       Impact factor: 0.975

  2 in total
  3 in total

Review 1.  Seasonal variation in blood pressure: current evidence and recommendations for hypertension management.

Authors:  Keisuke Narita; Satoshi Hoshide; Kazuomi Kario
Journal:  Hypertens Res       Date:  2021-09-06       Impact factor: 3.872

Review 2.  Impact of hyperuricemia on chronic kidney disease and atherosclerotic cardiovascular disease.

Authors:  Hitoshi Nishizawa; Norikazu Maeda; Iichiro Shimomura
Journal:  Hypertens Res       Date:  2022-01-19       Impact factor: 3.872

Review 3.  Update on Hypertension Research in 2021.

Authors:  Masaki Mogi; Tatsuya Maruhashi; Yukihito Higashi; Takahiro Masuda; Daisuke Nagata; Michiaki Nagai; Kanako Bokuda; Atsuhiro Ichihara; Yoichi Nozato; Ayumi Toba; Keisuke Narita; Satoshi Hoshide; Atsushi Tanaka; Koichi Node; Yuichi Yoshida; Hirotaka Shibata; Kenichi Katsurada; Masanari Kuwabara; Takahide Kodama; Keisuke Shinohara; Kazuomi Kario
Journal:  Hypertens Res       Date:  2022-07-05       Impact factor: 5.528

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.